When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Scarlet fever

Evidence last reviewed: 14 Sep 2026
Topic last updated: 09 Oct 2026

Summary

Definition

History and exam

Key diagnostic factors

  • scarlatiniform rash
  • fever (>100.4°F [>38.0°C])
  • sore throat
  • tonsillopharyngeal inflammation
  • tonsillopharyngeal exudate
  • palatal petechiae
  • anterior cervical adenitis
  • no viral symptoms (e.g., cough, rhinorrhea, hoarseness, mouth ulcers)
  • pyoderma
Full details

Other diagnostic factors

  • strawberry tongue
  • skin desquamation
  • headache
  • nausea
  • vomiting
  • abdominal pain
Full details

Risk factors

  • group A streptococcus pharyngitis
  • close contact with a person with scarlet fever or other group A streptococcus presentation
  • age 1-10 years
  • winter and spring seasons
  • crowded environment
  • close contact with children ages 1-10 years
  • nonpharyngitis group A streptococcus infection
Full details

Diagnostic tests

1st tests to order

  • rapid antigen detection test for group A streptococcus
Full details

Tests to consider

  • bacterial culture (throat, skin, wound, blood)
  • nucleic acid amplification tests for group A streptococcus
Full details

Treatment algorithm

ACUTE

all patients

Contributors

Authors

Alexandra Brugler Yont​s, MD

Attending Physician

Pediatric Infectious Diseases

Children's National Hospital

Assistant Professor of Pediatrics

The George Washington University School of Medicine and Health Sciences

Washington, DC

Disclosures

ABY is employed full-time as a Pediatric Infectious Diseases physician by Children's National Hospital. As an Investigator, her department has received institutional grant money (not in the form of salary support) for clinical trials (unrelated to the article topic) sponsored by Pfizer for which there is no contractual agreement to disseminate product information. ABY has received honoraria for multiple lectures given at academic institutions and professional organizations covering topics unrelated to this module. ABY briefly served on a US federal government advisory committee on Long COVID, which has since been disbanded, and she currently serves as a member of the Long COVID Families Scientific Board, both of which are unpaid roles.

Peer reviewers

Monika Dietrich, ​MD, FAAP

​Assistant Professor of Pediatrics

Section of Pediatric Infectious Disease

Children's Hospital New Orleans

Tulane University School of Medicine

Tulane

New Orleans, LA

Disclosures

MD declares that she has no competing interests.

Theresa Lamagni​, BSc MSc PhD

Head of Gram Positive Infection

Healthcare-Associated Infection & Antimicrobial Resistance Division

UK Health Security Agency (UKHSA)

London

UK

Disclosures

TL declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Centers for Disease Control and Prevention. Clinical guidance for scarlet fever. Feb 2026 [internet publication].Full text

Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012 Nov 15;55(10):e86-102. [Erratum in: Clin Infect Dis. 2014 May;58(10):1496.]Full text  Abstract

Linder JA, Watson ME, Wessels MR, et al. 2025 clinical practice guideline update by the Infectious Diseases Society of America on group A streptococcal pharyngitis: risk assessment using clinical scoring systems in children and adults. Clin Infect Dis. 2026 Aug 24;82(suppl 3):i97-104.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Scarlet fever images
  • Differentials

    • Kawasaki disease
    • Erythema infectiosum (parvovirus B19, fifth disease)
    • Rubella
    More Differentials
  • 指南

    • 2025 clinical practice guideline update by the Infectious Diseases Society of America on group A streptococcal (GAS) pharyngitis: risk assessment using clinical scoring systems in children and adults
    • WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease
    More 指南
  • 患者教育信息

    Tonsillitis

    更多 患者教育信息
  • 医学计算器

    Sore Throat (Pharyngitis) Evaluation and Treatment Criteria (McIsaac)

    更多 医学计算器
  • padlock-locked登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容

内容使用需遵循免责声明